Distribution in Tissue and Biosynthesis of ABO Blood Group Substances Specific for Tissue.
组织中的分布和组织特异性 ABO 血型物质的生物合成。
基本信息
- 批准号:03454214
- 负责人:
- 金额:$ 1.98万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1991
- 资助国家:日本
- 起止时间:1991 至 1992
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In this study, the monoclonal antibody defining tissue-specific epitope on the ABO blood group substances in salvia, which has been already produced by us, was first applied for investigation to the distribution of the ABO blood group substances in salival gland. In the microscopic and electron microscopic observation using fluorescence or gold colloid conjugated blood group antibody as a second antibody, the antibody reacted with only mucous cells in salival gland, but not react with the the those in salival gland of other primates and animals. Unfortunately, the intracellular distribution of the ABO blood group substances or its precursors ws not obvious, since salival gland used in this experiment was collected from cadavers.Next, we established a monoclonal antibody specific for intestinal metaplasia. It was made clear that the antibody recognized the carbohydrate chain expressing in only intestinal metaplasia of stomach, and that the carbohydrate chain carrying ABO and Lewis blood group activities also existed on the glycoprotein molecules defined by the antibody. Since it is well known that the tissue of intestinal metaplasia shows lower activity of ABO and Lewis blood groups than normal tissues, it seems that the carbohydrate chain recognized by the antibody is a precursor or a precursor-like material of the carbohydrate chain active to ABO and Lewis blood groups in the biosynthetic pathway. Furthermore, about millions kD antigenic glycoprotein could be purified in the affinity chromatography using the antibody. Therefore, we consider to clear biosynthetic pathway of the ABO blood group substances in the tissue by purifying of the antigenic glycoprotein from a large amount of gastric mucosa, and by making out obvious the structure of the carbohydrate chain defined by this antibody.
本研究首次将我们已制备的ABO血型物质组织特异性表位单克隆抗体应用于研究ABO血型物质在唾液腺中的分布。用荧光或胶体金标记的血型抗体作为第二抗体,在显微镜和电镜下观察,该抗体只与唾液腺中的粘液细胞发生反应,而不与其他灵长类动物和动物唾液腺中的粘液细胞发生反应。由于本实验所用的唾液腺是从尸体上采集的,因此ABO血型物质或其前体物质在唾液腺细胞内的分布不明显。表明该抗体识别的糖链仅在胃肠化组织中表达,而携带ABO和刘易斯血型活性的糖链也存在于该抗体所识别的糖蛋白分子上。众所周知,肠上皮化生组织的ABO和刘易斯血型活性低于正常组织,因此,抗体识别的碳水化合物链似乎是生物合成途径中对ABO和刘易斯血型有活性的碳水化合物链的前体或类似于碳水化合物的物质。利用该抗体进行亲和层析,可纯化出数百万kD的抗原糖蛋白。因此,我们考虑通过从大量胃粘膜中纯化抗原性糖蛋白,并明确该抗体所定义的糖链结构,以明确组织中ABO血型物质的生物合成途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TSUJI Tsutomu其他文献
TSUJI Tsutomu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TSUJI Tsutomu', 18)}}的其他基金
Modulation by cytokines of integrin-dependent cancer cell adhesion/invasion to peritoneum
细胞因子对整合素依赖性癌细胞粘附/侵袭腹膜的调节
- 批准号:
23590092 - 财政年份:2011
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The integrin-matrix interaction in the metastasis and invasion processes of cancer
癌症转移和侵袭过程中整合素-基质相互作用
- 批准号:
19590084 - 财政年份:2007
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Regulation of platelet-leukocyte interaction and pharmaceutical application
血小板-白细胞相互作用的调节及药物应用
- 批准号:
13557213 - 财政年份:2001
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Characterization of VLA-3 integrin-mediated adhesion and its expre ision in cancer cells
VLA-3整合素介导的粘附的表征及其在癌细胞中的表达
- 批准号:
13672308 - 财政年份:2001
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role of VLA-3 integrin in adhesion of cancer cells to peritoneum.
VLA-3 整合素在癌细胞粘附腹膜中的作用。
- 批准号:
11672192 - 财政年份:1999
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Relation between activity control of neutrophils and ingestion in inflammation
中性粒细胞活性控制与炎症摄入之间的关系
- 批准号:
11670426 - 财政年份:1999
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Structure and function of a variation of sialyl Lewis X carbohydrate chains on glycoproteins.
糖蛋白上唾液酸路易斯 X 碳水化合物链变体的结构和功能。
- 批准号:
09672218 - 财政年份:1997
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Expression of brain/embryo-type myosin heavy chain isoform in the healing process of damaged tissue
脑/胚胎型肌球蛋白重链亚型在受损组织愈合过程中的表达
- 批准号:
09670448 - 财政年份:1997
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cell-Biological Study on Medicolegal Diagnosis of Injury
损伤法医学诊断的细胞生物学研究
- 批准号:
07457118 - 财政年份:1995
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of anti-inflammatory drugs affecting functions of platelet adhesion molecules
影响血小板粘附分子功能的抗炎药物的开发
- 批准号:
06557134 - 财政年份:1994
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
相似海外基金
PHASE 1 TRIAL FOR A THERAPEUTIC MONOCLONAL ANTIBODY FOR CHIKUNGUNYA VIRUS
基孔肯雅病毒治疗性单克隆抗体的第一阶段试验
- 批准号:
10892414 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
Base Title: PREVENT Preclinical Pharmacology and ToxicologyTask Order Title: Nicotine Reduction Therapy Using the Human Monoclonal Antibody ATI-1013
基本标题:预防临床前药理学和毒理学任务订单标题:使用人单克隆抗体 ATI-1013 进行尼古丁减少治疗
- 批准号:
10932479 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
Monoclonal Antibody to Combat Pseudomonas Aeruginosa
对抗铜绿假单胞菌的单克隆抗体
- 批准号:
10674274 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
Monoclonal Antibody Cocktail for Treatment of Marburg Virus Disease
用于治疗马尔堡病毒病的单克隆抗体混合物
- 批准号:
10761372 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
Targeting a ectonucleotidase in the heart with a monoclonal antibody to prevent post-infarct heart failure
用单克隆抗体靶向心脏中的核酸外切酶以预防梗死后心力衰竭
- 批准号:
10711469 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
Epitope-directed monoclonal antibody production for mosquito immune cells (for malaria)
针对蚊子免疫细胞(针对疟疾)的表位定向单克隆抗体生产
- 批准号:
10933280 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
On-cell screening of mouse hybridomas for improved monoclonal antibody discovery
小鼠杂交瘤的细胞筛选以改进单克隆抗体的发现
- 批准号:
10696698 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
Assessment of self-association of monoclonal antibody molecules by analysis of the protein layer detected at the proximity of a solid surface
通过分析在固体表面附近检测到的蛋白质层来评估单克隆抗体分子的自缔合
- 批准号:
10726173 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
STTR Phase I: Developing antifouling viral clearance membranes to enable efficient monoclonal antibody (mAb) processing
STTR 第一阶段:开发防污病毒清除膜以实现高效的单克隆抗体 (mAb) 处理
- 批准号:
2212947 - 财政年份:2022
- 资助金额:
$ 1.98万 - 项目类别:
Standard Grant
Development of transportable scFV monoclonal antibody into nucleus
可转运的scFV单克隆抗体进入细胞核的开发
- 批准号:
22K19387 - 财政年份:2022
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)














{{item.name}}会员




